🇺🇸
United States · US · US:71288-117_c5bbcd6c-28a2-4db0-86dd-4c9ce60a434f
Gemcitabine
In shortageOrange BookUNIISPLATC L01BC05
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerMeitheal Pharmaceuticals Inc.
CountryUS (United States)
ATC codeL01BC05
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc1171288117061 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-06) / 5.26 mL in 1 VIAL, SINGLE-DOSE
- ndc1171288117281 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-28) / 26.3 mL in 1 VIAL, SINGLE-DOSE
- ndc1171288117541 VIAL, SINGLE-DOSE in 1 CARTON (71288-117-54) / 52.6 mL in 1 VIAL, SINGLE-DOSE
Annotations
UNII (FDA Substance ID)
U347PV74IL
GEMCITABINE HYDROCHLORIDE
RxCUI 236234
Orange Book
A212129
APAPAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Gemcitabine Hydrochloride Injection
Raw payload (JSON)
{
"unii": {
"unii": "U347PV74IL",
"rxcui": "236234",
"inchikey": "OKKDEIYWILRZIA-OSZBKLCCSA-N",
"display_name": "GEMCITABINE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"dc02a23b-3ff9-4441-aa91-8e9e629a7315": {
"match": "brand_token",
"title": "GEMCITABINE INJECTION, SOLUTION [HOSPIRA, INC.]",
"spl_version": "28",
"published_date": "2026-04-29"
}
},
"productid": "71288-117_c5bbcd6c-28a2-4db0-86dd-4c9ce60a434f",
"productndc": "71288-117",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "212129",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "200MG/5.26ML (38MG/ML)",
"product_no": "001",
"approval_date": "Dec 11, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "1GM/26.3ML (38MG/ML)",
"product_no": "002",
"approval_date": "Dec 11, 2020"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "2GM/52.6ML (38MG/ML)",
"product_no": "003",
"approval_date": "Dec 11, 2020"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "GEMCITABINE HYDROCHLORIDE",
"shortage_reason": "Gemcitabine Hydrochloride Injection",
"shortage_status": "current",
"proprietary_name": "Gemcitabine",
"active_ingred_unit": "mg/mL",
"application_number": "ANDA212129",
"marketing_category": "ANDA",
"nonproprietary_name": "Gemcitabine hydrochloride",
"start_marketing_date": "20201211",
"active_numerator_strength": "38"
}Related drugs
Other records sharing ATC code L01BC05.
- 🇺🇸AVGEMSIAvyxa Pharma, LLC
- 🇺🇸AVGEMSIAvyxa Pharma, LLC
- DKGemcitabin "Accord"Accord Healthcare B.V.
- DKGemcitabin "Sandoz"Sandoz A/S
- DKGemcitabin "SUN"SUN Pharmaceutical Industries Europe BV
- 🇨🇭Gemcitabin AccordAccord Healthcare AG
- 🇨🇭Gemcitabin AccordAccord Healthcare AG
- 🇨🇭Gemcitabin AccordAccord Healthcare AG
Access this data programmatically
Query Gemcitabine and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.